TC BioPharm (Holdings) plc Warrants
TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on the development of immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline includes OmnImmune, an allogeneic unmodified gamma-delta T cell therapy product under Phase 2/3 trails for the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat … Read more
Market Cap & Net Worth: TC BioPharm (Holdings) plc Warrants (TCBPW)
TC BioPharm (Holdings) plc Warrants (NASDAQ:TCBPW) has a market capitalization of $55.03 ($55.03) as of March 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #37109 globally and #12079 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying TC BioPharm (Holdings) plc Warrants's stock price $0.01 by its total outstanding shares 9171 (9.17K).
TC BioPharm (Holdings) plc Warrants Market Cap History: 2022 to 2025
TC BioPharm (Holdings) plc Warrants's market capitalization history from 2022 to 2025. Data shows change from $1.28K to $55.03 (-76.80% CAGR).
TC BioPharm (Holdings) plc Warrants Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how TC BioPharm (Holdings) plc Warrants's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
TC BioPharm (Holdings) plc Warrants's market cap is 0.00 times its annual revenue
1742.66x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $1.28K | $3.84 Million | -$1.31 Million | 0.00x | N/A |
Competitor Companies of TCBPW by Market Capitalization
Companies near TC BioPharm (Holdings) plc Warrants in the global market cap rankings as of March 18, 2026.
Key companies related to TC BioPharm (Holdings) plc Warrants by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #158 globally with a market cap of $118.01 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.58 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #158 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $118.01 Billion | $466.10 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.58 Billion | $756.91 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
TC BioPharm (Holdings) plc Warrants Historical Marketcap From 2022 to 2025
Between 2022 and today, TC BioPharm (Holdings) plc Warrants's market cap moved from $1.28K to $ 55.03, with a yearly change of -76.80%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $55.03 | -39.39% |
| 2024 | $90.79 | -69.54% |
| 2023 | $298.06 | -76.79% |
| 2022 | $1.28K | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of TC BioPharm (Holdings) plc Warrants was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $55.03 USD |
| MoneyControl | $55.03 USD |
| MarketWatch | $55.03 USD |
| marketcap.company | $55.03 USD |
| Reuters | $55.03 USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.